Title
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
Date Issued
01 November 2014
Access level
metadata only access
Resource Type
review
Author(s)
LLerena A.
Naranjo M.E.G.
Rodrigues-Soares F.
Penas-LLedó E.M.
Fariñas H.
Universidade Federal de Minas Gerais
Publisher(s)
Informa Healthcare
Abstract
Introduction: The frequency of CYP2D6 alleles, related to either a lack of or increased enzymatic activity, which may lead to poor metabolism (PM) or ultrarapid metabolism (UM), can vary across ethnic groups and hence across geographic regions. Areas covered: Worldwide original research papers on CYP2D6 allelic frequencies, metabolic phenotype frequencies measured with a probe drug, and/or genotype frequencies that studied > 50 healthy volunteers, were included in analyses to describe the distributions of alleles, phenotypes predicted from genotypes (predicted poor metabolizers [gPMs], predicted ultrarapid metabolizers [gUMs]) and metabolic phenotypes (mPMs, mUMs) across ethnic groups and geographic regions. The analysis included 44,572 individuals studied in 172 original research papers. Expert opinion: As of today, Africa and Asia are under-represented in this area relative to the total number of their inhabitants, so that further studies in these regions are warranted. The CYP2D6∗4 allele frequency was higher in Caucasians, CYP2D6∗10 in East Asians, CYP2D6∗41 and duplication/multiplication of active alleles in Middle Easterns, CYP2D6∗17 in Black Africans and CYP2D6∗29 in African Americans, than in other ethnic groups. Overall, gPMs and mPMs aremore frequentamong Caucasians, and gUMs among Middle Easterns and Ethiopians. However, mUMs could not be evaluated because only two studies were found presenting this information. Further studies including mUMs are thus warranted. There is a correspondence between gPMs and mPMs, but the few studies of mUMs meant that their relationship with gUMs could not be demonstrated. Finally, evolutionary aspects of the CYP2D6 allele distribution appear to support the Great Human Expansion model.
Start page
1569
End page
1583
Volume
10
Issue
11
Language
English
OCDE Knowledge area
Geografía económica y cultural
Etnología
Subjects
Scopus EID
2-s2.0-84911392539
PubMed ID
Source
Expert Opinion on Drug Metabolism and Toxicology
ISSN of the container
17425255
Sponsor(s)
This study was partially supported by the European Union FEDER/FSE and the Gobierno de Extremadura Consejería de Empleo, Empresa e Innovación (PD10199), and AEXCID Cooperación Extremeña (13IA001) coordinated in the Iber-oamerican Network of Pharmacogenetics (SIFF) and Brazilian Government CAPES grants (99999.012350/2013-03 and 110/2012). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Sources of information:
Directorio de Producción Científica
Scopus